World’s first 100% HIV prevention drug unveiled

Over 1.03 million people are infected with HIV every year across the world. While AIDS-related deaths have significantly declined in recent years—thanks to widespread access to antiretroviral therapy (ART)—scientists have now achieved a major breakthrough in the decades-long fight against AIDS. For the first time, a 100% effective HIV prevention drug has been developed. This drug, called “Sunlenca” under the brand name “Lenacapavir,” is administered via a biannual injection and is now on the path to global distribution, potentially saving millions of lives.